The Effective Date of the Dex Liquidating Co. confirmed Chapter 11 Plan of Liquidation (the “Plan”) occurred at the close of business on November 28, 2018.
Based on currently available information, Dex Liquidating Co., formerly Dextera Surgical Inc., does not expect to make any cash distributions to holders of Class 4 Interests (former Series B Preferred Stock) or Class 5 Interests (former Common Stock) under the Plan until after resolution of the Aesculap Escrow (as defined in the Plan). The Aesculap Escrow is scheduled to remain in place until February 2020. Any distributions made will be to holders of record as of the close of business on November 28, 2018 as per the Plan.
On the Effective Date (1) the Notice of Occurrence of Effective Date of the Plan was filed with the Bankruptcy Court, (2) all of the Company’s securities were cancelled, and (3) the registration of the Company’s Common Stock under the Securities Exchange Act of 1934 was cancelled.
Clicking the button below will take you directly to the external SEC EDGAR website
where you can find the historical SEC filings by the Company. As noted above, the registration of the Company’s Common Stock under the Securities Exchange Act of 1934 was cancelled.